Large-scale testing (Phase 3)Study completedNCT00319033What this trial is testingOpen-label Study With Bosentan in Interstitial Lung DiseaseWho this might be right forInterstitial Lung DiseaseScleroderma Actelion 132
Early research (Phase 1)Study completedNCT03675581What this trial is testingTest Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)Who this might be right forScleroderma, Systemic Boehringer Ingelheim 17
Not applicableLooking for participantsNCT01776398What this trial is testingCollection of Airway, Blood and/or Urine Specimens From Subjects for Research StudiesWho this might be right forChronic Obstructive Pulmonary Disease (COPD)SmokingSmoking Cessation+3 more Weill Medical College of Cornell University 2,000
Not applicableUnknownNCT05450276What this trial is testingPatient-Reported Outcome Study of Project ECHO for ILDWho this might be right forInterstitial Lung Disease Pulmonary Care and Research Collaborative Limited 56
Large-scale testing (Phase 3)Study completedNCT01862926What this trial is testingRituximab Versus Cyclophosphamide in Connective Tissue Disease-ILDWho this might be right forInterstitial Lung DiseaseSclerodermaIdiopathic Inflammatory Myositis+1 more Royal Brompton & Harefield NHS Foundation Trust 104
Testing effectiveness (Phase 2)Looking for participantsNCT06189495What this trial is testingA Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung DiseaseWho this might be right forSystemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicableUnknownNCT06105073What this trial is testing"Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis"Who this might be right forSystemic Sclerosis Associated Interstitial Lung Disease Coordinación de Investigación en Salud, Mexico 67
Large-scale testing (Phase 3)Study completedNCT03313180What this trial is testingA Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung FibrosisWho this might be right forLung Diseases, Interstitial Boehringer Ingelheim 444
Not applicableActive Not RecruitingNCT04325217What this trial is testingPost-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in JapanWho this might be right forLung Diseases, Interstitial Boehringer Ingelheim 586
Not applicableEnrolling By InvitationNCT06472362What this trial is testingChest CT Biomarkers as Prognostic Predictors in SSc-ILDWho this might be right forSystemic Sclerosis Royal Brompton & Harefield NHS Foundation Trust 1,000
Not applicableActive Not RecruitingNCT07080125What this trial is testingA Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung FibrosisWho this might be right forInterstitial Lung DiseasesSystemic Sclerosis Associated Interstitial Lung Disease Boehringer Ingelheim 2,000
Not applicableUnknownNCT05445817What this trial is testingPulmonary Care and Research Collaborative Patient RegistryWho this might be right forInterstitial Lung Disease Pulmonary Care and Research Collaborative Limited 150
Not applicableLooking for participantsNCT05482607What this trial is testingEvaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung DiseaseWho this might be right forSystemic SclerosisInterstitial Lung Disease Central Hospital, Nancy, France 100
Large-scale testing (Phase 3)Study completedNCT00070590What this trial is testingEfficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With SclerodermaWho this might be right forPulmonary FibrosisScleroderma, Systemic Actelion 132
Large-scale testing (Phase 3)UnknownNCT03856853What this trial is testingEfficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung DiseaseWho this might be right forSystemic Sclerosis-associated Interstitial Lung Disease (Ssc-ild) Beijing Continent Pharmaceutical Co, Ltd. 144
Testing effectiveness (Phase 2)Study completedNCT01988506What this trial is testingInduction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesWho this might be right forRheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more Assistance Publique - Hôpitaux de Paris 81
Large-scale testing (Phase 3)Study completedNCT01748084What this trial is testingRituximab in Systemic SclerosisWho this might be right forSystemic Sclerosis Assistance Publique - Hôpitaux de Paris 22
Not applicableUnknownNCT03840928What this trial is testingPatientSpot Formerly Known as ArthritisPowerWho this might be right forRheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more Global Healthy Living Foundation 40,000
Post-approval studies (Phase 4)Looking for participantsNCT07087912What this trial is testingSafety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesWho this might be right forRheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)+9 more University of Sao Paulo General Hospital 477
Not applicableWithdrawnNCT05177471What this trial is testingEfficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung DiseaseWho this might be right forSystemic SclerosisInterstitial Lung Disease Central Hospital, Nancy, France